# Omnix Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/omnix-medical

- Industry: Biotechnology
- Headquarters: Jerusalem, Israel
- Website: www.omnixmedical.com
- Total disclosed funding: $25M
- Latest round: Series C (Oct 15, 2025)
- Investors on record: 8

## About

Founded in 2015 and based in Jerusalem, Israel, Omnix Medical Ltd. operates as a biopharmaceutical company that provides antimicrobial peptide-based treatments for drug-resistant bacterial infections. In October 2025, Omnix Medical Ltd. raised USD 25 million in series C funding co-led by new investors European Innovation Council and Harel Insurance Investments, with participation from other new investors Prevail Partners and OurCrowd. Returning investors Entree Capital, Tal ventures, Xenia Venture Capital, Oriella Ltd, and other unspecified investors also participated in the round.

## Funding rounds

- Series C, Oct 15, 2025, $25M — Harel Insurance Investments, Xenia Venture Capital, Entree Capital, OurCrowd, Oriella Ltd, Tal Ventures, Prevail Partners, European Innovation Council

## Investors

- Harel Insurance Investments — Series C
- Xenia Venture Capital (https://capitalatlas.ai/funds/xenia-venture-capital) — Series C
- Entree Capital (https://capitalatlas.ai/funds/entree-capital) — Series C
- OurCrowd (https://capitalatlas.ai/funds/ourcrowd) — Series C
- Oriella Ltd — Series C
- Tal Ventures (https://capitalatlas.ai/funds/tal-ventures) — Series C
- Prevail Partners (https://capitalatlas.ai/funds/prevail-partners) — Series C
- European Innovation Council (https://capitalatlas.ai/funds/european-innovation-council) — Series C